AVDL
Avadel Pharmaceuticals
AVDL
AVDL
80 hedge funds and large institutions have $189M invested in Avadel Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 27 increasing their positions, 23 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
13% less capital invested
Capital invested by funds: $217M → $189M (-$27.5M)
23% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 13
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
80
Holding in Top 10
–
Calls
$1.04M
Puts
$1.09M
Top Buyers
| 1 | +$10.9M | |
| 2 | +$6.2M | |
| 3 | +$1.53M | |
| 4 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$1.39M |
| 5 |
AC
Armistice Capital
New York
|
+$1.08M |
Top Sellers
| 1 | -$7.99M | |
| 2 | -$4.15M | |
| 3 | -$3.13M | |
| 4 |
Renaissance Technologies
New York
|
-$2.64M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$1.74M |